The Latest Cardiac and Vascular News
WALTHAM, Mass., April 12, 2022 /PRNewswire/ — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that on April 5, 2022, the compensation committee of the company’s board of directors granted five new non-executive employees options […]
VANCOUVER, April 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General and Special Meeting of Shareholders held on April 12, 2022 in Vancouver, B.C. (the “Meeting”). At the Meeting, the […]
MORRISVILLE, N.C., April 12, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) announced today that it has commenced an underwritten public offering of its common stock. All of the shares in the proposed offering will be sold by Liquidia. In addition, Liquidia expects to grant the underwriters a 30-day […]
77K square-foot facility to accommodate growth NEWTON, Mass.–(BUSINESS WIRE)–Corindus, A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today the opening of its new headquarters at 275 Grove Street in Newton, Mass. Siemens Healthineers relocated the Corindus headquarters from its previous location in Waltham to accommodate […]
The state-of-the-art cGMP facility, located in Sarasota, will help further solidify Florida as a global leader in biosciences SARASOTA, Fla.–(BUSINESS WIRE)–Akron Bio, a leading developer and manufacturer of critical building blocks used by biopharma to produce advanced therapies for the prevention and treatment of cardiovascular diseases and cancers, today launched […]
Esteemed vascular surgeon brings 10+ years of experience to patients in lower Fairfield County DARIEN, Conn.–(BUSINESS WIRE)–Vascular Care Connecticut, a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, is pleased to announce that Ksenia Orlova, MD, PhD, joined the Darien, Conn. center. Dr. Orlova brings […]
alfapump® in liver disease Positive results from second interim analysis of POSEIDON pivotal study; encouraging survival data at 12 months vs. published literature Patient enrolment and implants completed; primary endpoint on track for Q4 2022 FDA regulatory submission planned for mid-2023 DSR® in heart failure RED DESERT study demonstrated safety, cardio-renal benefit and long-term improvement in diuretic response SAHARA DESERT study interim data shows ability […]
~ Acquisition brings highly differentiated, proprietary biomaterial technologies for implantable cardiovascular devices to enable our customers’ innovation ~ PLANO, Texas, April 07, 2022 (GLOBE NEWSWIRE) — Today, Integer Holdings Corporation (NYSE: ITGR) announced the acquisition of Connemara Biomedical Holdings Teoranta, including its operating subsidiaries Aran Biomedical and Proxy Biomedical (collectively […]
Fiscal 2022 Third Quarter Highlights Net sales of $74.0 million increased 3.9% compared to the prior-year quarter Med Tech grew 28.6% and Med Device declined 2.8% year over year Gross margin of 52.2% declined 190 basis points year over year GAAP loss per share of $0.13 and adjusted earnings per […]
MONMOUTH JUNCTION, N.J., April 7, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that it has received approximately $740,000, net of transactions costs, in cash proceeds from the sale of its 2020 Net Operating Loss (NOL) and […]
